Search

Your search keyword '"Griffiths, Anthony"' showing total 18 results

Search Constraints

Start Over You searched for: Author "Griffiths, Anthony" Remove constraint Author: "Griffiths, Anthony" Topic covid-19 Remove constraint Topic: covid-19
18 results on '"Griffiths, Anthony"'

Search Results

1. Monovalent SARS-COV-2 mRNA vaccine using optimal UTRs and LNPs is highly immunogenic and broadly protective against Omicron variants.

2. A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta.

3. The variable conversion of neutralizing anti-SARS-CoV-2 single-chain antibodies to IgG provides insight into RBD epitope accessibility.

4. IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern.

6. IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2.

7. Fecal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) RNA Is Associated With Decreased Coronavirus Disease 2019 (COVID-19) Survival.

8. Secondary structural ensembles of the SARS-CoV-2 RNA genome in infected cells.

9. A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 Antigens.

10. An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates.

11. Biomaterials and Oxygen Join Forces to Shape the Immune Response and Boost COVID-19 Vaccines.

12. Rapid and Repetitive Inactivation of SARS-CoV-2 and Human Coronavirus on Self-Disinfecting Anionic Polymers.

13. SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms.

14. Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022.

15. Rapid and complete inactivation of SARS-CoV-2 by ultraviolet-C irradiation.

16. Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV‑2 Inhibition

17. Cellular Nanosponges Inhibit SARS-CoV‑2 Infectivity

18. Anti-SARS-CoV-2 Activity of Adamantanes In Vitro and in Animal Models of Infection.

Catalog

Books, media, physical & digital resources